Prognostic Values of SUVmax Value of PET/CT and CA19-9 as biologic markers in Patients with Pancreatic Ductal Adenocarcinoma

Authors :: W. Kwon
Yoojin Choi
Youngmin Han
Jin-Young Jang
D. Moon
Jae Seung Kang
Hongbeom Kim
Y. Byun
Source :: Pancreatology. 20:S151
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Biologic marker
medicine.medical_specialty
PET-CT
Pancreatic ductal adenocarcinoma
Hepatology
business.industry
Endocrinology, Diabetes and Metabolism
Gastroenterology
medicine
CA19-9
In patient
Radiology
business
Value (mathematics)

Full Text Access

Tools